![Christina Trojel-Hansen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Christina Trojel-Hansen is the founder of Oscine Corp.
She previously worked as a Senior Associate at Novo Seeds from 2016 to 2018.
Anciens postes connus de Christina Trojel-Hansen
| Sociétés | Poste | Fin |
|---|---|---|
Oscine Corp.
 Oscine Corp. BiotechnologyHealth Technology Develops cell therapies for diseases of the brain and central nervous system | Directeur Général | 01/09/2020 |
Novo Seeds
 Novo Seeds Investment ManagersFinance Novo Seeds invests in companies located in Europe and the United States. The fund targets companies operating in the fields of life science and healthcare technology sectors. It provides financing for seed and early stage capital requirement. | Analyste en capital-investissement | 01/04/2018 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Novo Seeds
Novo Seeds Investment ManagersFinance Novo Seeds invests in companies located in Europe and the United States. The fund targets companies operating in the fields of life science and healthcare technology sectors. It provides financing for seed and early stage capital requirement. | Finance |
Oscine Corp.
Oscine Corp. BiotechnologyHealth Technology Develops cell therapies for diseases of the brain and central nervous system | Health Technology |
Choisissez Zonebourse 
